| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 64,085 | 43,876 | 37,302 | 73,443 | | Cost of Revenue | 52,223 | 40,326 | 65,098 | 67,055 | | | Gross Profit | 11,862 | 3,550 | (27,796) | 6,388 | | | Operating Expenses | | Research Development | 7,115 | 7,549 | 7,666 | 9,277 | | Selling General and Administrative | 18,831 | 19,559 | 25,207 | 27,634 | | Non Recurring | 21,437 | 2,327 | 92,249 | 4,105 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,597) | (25,885) | (152,918) | (34,628) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 706 | 650 | 535 | (326) | | Earnings Before Interest And Taxes | (13,891) | (25,235) | (152,383) | (34,954) | | Interest Expense | 196 | 60 | 72 | 126 | | Income Before Tax | (14,087) | (25,295) | (152,455) | (35,080) | | Income Tax Expense | (85) | 148 | 189 | 391 | | Minority Interest | (22) | (240) | 90 | 87 | | | | Net Income From Continuing Ops | (14,490) | (25,742) | (152,543) | (35,083) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,490) | (25,742) | (152,543) | (35,083) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,490) | ($25,742) | ($152,543) | ($35,083) |
|
0.13% Nasdaq 
0.30%
Income Statement
